BE (Q82441)

From MaRDI portal

!

This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:

BE

Bioequivalence Study Data Analysis
Language Label Description Also known as
default for all languages
No label defined
    English
    BE
    Bioequivalence Study Data Analysis

      Statements

      0 references
      0.2.4
      7 January 2023
      0 references
      0.1.0
      18 June 2018
      0 references
      0.1.1
      19 July 2018
      0 references
      0.1.2
      27 September 2020
      0 references
      0.1.3
      21 June 2021
      0 references
      0.1.4
      16 November 2021
      0 references
      0.1.5
      16 December 2021
      0 references
      0.2.0
      1 April 2022
      0 references
      0.2.1
      9 May 2022
      0 references
      0.2.2
      6 August 2022
      0 references
      0.2.3
      7 September 2022
      0 references
      PACKAGES.rds
      9 July 2026
      0 references
      0.3.0
      29 July 2026
      0 references
      0 references
      0 references
      29 July 2026
      0 references
      Analyze bioequivalence study data with industrial strength. The statistical core is delegated to the 'sasLM' package, which reproduces 'SAS' PROC GLM output; this covers the analysis of variance, the least square means, and the confidence interval of a 2x2 crossover study. Sample size could be determined for various crossover designs, such as 2x2 design, 2x4 design, 4x4 design, Balaam design, Two-sequence dual design, and William design. Reference: Chow SC, Liu JP. Design and Analysis of Bioavailability and Bioequivalence Studies. 3rd ed. (2009, ISBN:978-1-58488-668-6).
      0 references
      0 references
      0 references

      Identifiers

      0 references
       
      • mardi BE